Detailed list of Quality assessment criteria and assessment procedures (D2.2)
Lead Contributors: Jaap Trappenburg, Arnela Suman (UMCU)
August 25, 2020
![feature-image_news-01 *](https://trialsathome.com/wp-content/uploads/2019/12/feature-image_news-01-1.jpg)
This report describes the development of the quality criteria and assessment procedures for the quality assessment of the technologies for the pan-European pilot study. The final set of quality criteria and assessment procedures to be used are presented. This report can be adjusted based on ESP and ExBo feedback.
![partners_logos_imi IMI](https://trialsathome.com/wp-content/uploads/2019/12/partners_logos_imi.jpg)
![partners_logos_efpia EFPIA](https://trialsathome.com/wp-content/uploads/2019/12/partners_logos_efpia.jpg)
![partners_logos-euro EU](https://trialsathome.com/wp-content/uploads/2019/12/partners_logos-euro.jpg)
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 831458. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Notes for editors – not for publication
If you would like more information, please contact the spokesperson at the UMC Utrecht.
Joris Prinssen: +31 6 2571 0234
press@umcutrecht.nl